Home4582 • TYO
add
Symbio Pharmaceuticals Ltd
Previous close
¥248.00
Day range
¥241.00 - ¥248.00
Year range
¥146.00 - ¥475.00
Market cap
11.03B JPY
Avg Volume
312.49K
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
Market news
Financials
Income Statement
Revenue
Net income
| (JPY) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 613.94M | -50.61% |
Operating expense | 1.52B | 22.85% |
Net income | -1.30B | -83.88% |
Net profit margin | -212.35 | -272.28% |
Earnings per share | — | — |
EBITDA | -1.05B | -403.02% |
Effective tax rate | -0.37% | — |
Balance Sheet
Total assets
Total liabilities
| (JPY) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.13B | -16.11% |
Total assets | 6.07B | -28.20% |
Total liabilities | 910.31M | 17.61% |
Total equity | 5.16B | — |
Shares outstanding | 45.83M | — |
Price to book | 2.20 | — |
Return on assets | -40.26% | — |
Return on capital | -46.17% | — |
Cash Flow
Net change in cash
| (JPY) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.30B | -83.88% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
Mar 25, 2005
Headquarters
Website
Employees
109
